{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:49:53Z","timestamp":1778154593630,"version":"3.51.4"},"reference-count":52,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Musculoskeletal"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disease, and a predicting clinical improvement is essential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>The aim of the present study was to identify predictor variables of clinical improvement in patients with RA using artificial intelligence (AI) models in a specialized RA center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort study in adult RA patients was conducted between January and June 2022. Follow-up data related to clinical improvement was taken from 6 to 12\u2009months after the baseline. Predictive models were generated by machine learning (ML), by Python programming language. The Transparent Reporting of a multivariate prediction model for Individual Prognosis or Diagnosis (TRIPOD) guidelines were followed to harmonize this study based on AI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The response variable was classified as improved and non-improved. Patients were considered improved if they persisted or achieved a Disease Activity Score 28\u2014joints (DAS28) &lt;3.2 at the end of the follow-up period or experienced a decrease \u2a7e0.6 compared to baseline, regardless of the initial DAS28 value. Explainability techniques in AI were applied to identify the most relevant clinical features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In total, 3161 RA patients were included. The median age was 65\u2009years (interquartile range (IQR) 57\u201372). 82.7% were female. Disease duration was 8.3\u2009years (IQR 4.9\u201311.3). The median value of baseline DAS28 was 2.1 (IQR 2.1\u20132.8). 2668 (84.4%) were classified as improved, and 493 (15.6%) as non-improved. From ML models, the Extra tree model showed higher sensitivity (0.841). Regarding clinical improvement prediction with the Shapley Additive Explanations method, it was observed that low values of baseline DAS28 were positively associated with clinical improvement. The use of biologic disease-modifying antirheumatic drugs and the presence of anti-cyclic citrullinated peptide (CCP) were related to an increase in the probability of non-improved, which may be secondary to the level of severity of the disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>AI models in RA can predict clinical improvement at initial consultations, enabling targeted approaches. Disease severity may be influenced by anti-CCP positivity and the use of biologic therapies when conventional treatments fail.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1759720x251342426","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T09:48:09Z","timestamp":1750067289000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and evaluation of a multivariable prediction model for clinical improvement in an established cohort of Colombian rheumatoid arthritis patients"],"prefix":"10.1177","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6063-277X","authenticated-orcid":false,"given":"Claudia","family":"Ib\u00e1\u00f1ez-Antequera","sequence":"first","affiliation":[{"name":"Vice-Rectory of Research Fundaci\u00f3n Universitaria de Ciencias de la Salud, Bogot\u00e1, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel-Santiago","family":"Rodr\u00edguez-Vargas","sequence":"additional","affiliation":[{"name":"Research Department, BIOMAB\u2014Center for Rheumatoid Arthritis, Bogot\u00e1, Colombia"},{"name":"Internal Medicine Department, Universidad el Bosque, Bogot\u00e1, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1887-7161","authenticated-orcid":false,"given":"Fernando","family":"Rodr\u00edguez-Florido","sequence":"additional","affiliation":[{"name":"Research Department, BIOMAB\u2014Center for Rheumatoid Arthritis, Bogot\u00e1, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Rodr\u00edguez-Linares","sequence":"additional","affiliation":[{"name":"Research Department, BIOMAB\u2014Center for Rheumatoid Arthritis, Bogot\u00e1, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3145-2440","authenticated-orcid":false,"given":"Adriana","family":"Rojas-Villarraga","sequence":"additional","affiliation":[{"name":"Research Institute, Fundaci\u00f3n Universitaria de Ciencias de la Salud, Bogot\u00e1, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-0317","authenticated-orcid":false,"given":"Pedro","family":"Santos-Moreno","sequence":"additional","affiliation":[{"name":"BIOMAB\u2014Center for Rheumatoid Arthritis, Calle 48 #13-86, Bogot\u00e1 110221, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200367"},{"key":"e_1_3_4_4_2","first-page":"245","article-title":"Prevalencia de la enfermedad reum\u00e1tica en Colombia, seg\u00fan estrategia COPCORD-Asociaci\u00f3n Colombiana de Reumatolog\u00eda. Estudio de prevalencia de enfermedad reum\u00e1tica en poblaci\u00f3n colombiana mayor de 18 a\u00f1os","volume":"25","author":"Londo\u00f1o J","year":"2018","unstructured":"Londo\u00f1o J, Pel\u00e1ez Ballestas I, Cuervo F, et al. Prevalencia de la enfermedad reum\u00e1tica en Colombia, seg\u00fan estrategia COPCORD-Asociaci\u00f3n Colombiana de Reumatolog\u00eda. Estudio de prevalencia de enfermedad reum\u00e1tica en poblaci\u00f3n colombiana mayor de 18 a\u00f1os. Rev Colomb Reumatol 2018; 25: 245\u2013256.","journal-title":"Rev Colomb Reumatol"},{"key":"e_1_3_4_5_2","first-page":"171","article-title":"Artritis reumatoide temprana","volume":"9","author":"Guzm\u00e1n Moreno R","year":"2002","unstructured":"Guzm\u00e1n Moreno R, Restrepo Su\u00e1rez JF. Artritis reumatoide temprana. Rev Colomb Reumatol 2002; 9: 171\u2013175.","journal-title":"Rev Colomb Reumatol"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12809"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-016-3246-5"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2015.11.009"},{"key":"e_1_3_4_10_2","first-page":"858","article-title":"Clinical outcomes in a cohort of Colombian patients with rheumatoid arthritis treated with Etanar, a new biologic type rhTNFR:Fc\u2014PubMed","volume":"33","author":"Santos-Moreno P","year":"2015","unstructured":"Santos-Moreno P, S\u00e1nchez G, Gomez D, et al. Clinical outcomes in a cohort of Colombian patients with rheumatoid arthritis treated with Etanar, a new biologic type rhTNFR:Fc\u2014PubMed. Clin Exp Rheumatol 2015; 33: 858\u2013862.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.01.019"},{"key":"e_1_3_4_12_2","first-page":"40","article-title":"Depressive symptoms are independently associated with pain perception in Colombians with rheumatoid arthritis\u2014PubMed","volume":"40","author":"Rogers H","year":"2015","unstructured":"Rogers H, Brotherton HT, de Luis A, et al. Depressive symptoms are independently associated with pain perception in Colombians with rheumatoid arthritis\u2014PubMed. Acta Reumatol Port 2015; 40: 40\u201349.","journal-title":"Acta Reumatol Port"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000284"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24596"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S385423"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390105"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2009.10.001"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2017.01.011","article-title":"Artificial intelligence in medicine","volume":"69","author":"Hamet P","year":"2017","unstructured":"Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism 2017; 69S: S36\u2013S40.","journal-title":"Metabolism"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1308\/147870804290"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/13645706.2019.1575882"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001720"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05323-w"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-020-02180-w"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez194"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02635-3"},{"key":"e_1_3_4_27_2","article-title":"The health assessment questionnaire (HAQ)","volume":"23","author":"Bruce B","year":"2005","unstructured":"Bruce B, Fries JF. The health assessment questionnaire (HAQ). Clin Exp Rheumatol 2005; 23: S14\u2013S18.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105449"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2022.927312"},{"key":"e_1_3_4_32_2","first-page":"4766","article-title":"A unified approach to interpreting model predictions","volume":"2017","author":"Lundberg SM","year":"2017","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst 2017; 2017: 4766\u20134775.","journal-title":"Adv Neural Inf Process Syst"},{"key":"e_1_3_4_33_2","unstructured":"Gu\u00edo Espa\u00f1ol A Tamayo Uribe E G\u00f3mez Ayerbe P. Marco \u00e9tico para la inteligencia artificial en Colombia [Internet]. Bogot\u00e1 Ministry of Health of Colombia 2021 pp. 1\u201363 https:\/\/minciencias.gov.co\/sites\/default\/files\/marco-etico-ia-colombia-2021.pdf (accessed 5 June 2024)."},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02567-y"},{"key":"e_1_3_4_35_2","first-page":"171","article-title":"Genetics of rheumatoid arthritis: a new boost is needed in Latin American populations","volume":"56","author":"Castro-Santos P","year":"2016","unstructured":"Castro-Santos P, D\u00edaz-Pe\u00f1a R. Genetics of rheumatoid arthritis: a new boost is needed in Latin American populations. Rev Bras Reumatol 2016; 56: 171\u2013177.","journal-title":"Rev Bras Reumatol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04618-x"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.46856\/GRP.26.E125"},{"key":"e_1_3_4_38_2","unstructured":"Romero-S\u00e1nchez C Beltr\u00e1n-Ostos A. Aproximaciones de la inteligencia artificial aplicada en la inmunolog\u00eda de las enfermedades autoinmunes y autoinflamatorias https:\/\/aipocrates.blog\/2022\/11\/27\/aproximaciones-de-la-inteligencia-artificial-aplicada-en-la-inmunologia-de-las-enfermedades-autoinmunes-y-autoinflamatorias\/ (2022 accessed 1 January 2023)."},{"key":"e_1_3_4_39_2","first-page":"77","article-title":"Machine learning models in rheumatology","volume":"22","author":"Gonz\u00e1lez FA","year":"2015","unstructured":"Gonz\u00e1lez FA. Machine learning models in rheumatology. Revis Colomb Reumatol (Engl Ed) 2015; 22: 77\u201378.","journal-title":"Revis Colomb Reumatol (Engl Ed)"},{"key":"e_1_3_4_40_2","unstructured":"Morales Mu\u00f1oz LA. Modelo computacional para la identificaci\u00f3n de endofenotipos en pacientes con Artritis Reumatoide utilizando informaci\u00f3n del Ant\u00edgeno Leucocitario Humano HLA clase II [Internet]. Bogot\u00e1 Universidad Nacional de Colombia https:\/\/repositorio.unal.edu.co\/bitstream\/handle\/unal\/50373\/98400299.2014.pdf (2014 accessed 5 June 2014)."},{"key":"e_1_3_4_41_2","first-page":"90","article-title":"Modelo computacional para la identificaci\u00f3n de endofenotipos y clasificaci\u00f3n de pacientes con artritis reumatoide a partir de datos gen\u00e9ticos, serol\u00f3gicos y cl\u00ednicos, utilizando t\u00e9cnicas de inteligencia computacional","volume":"22","author":"Morales Mu\u00f1oz L","year":"2015","unstructured":"Morales Mu\u00f1oz L, Quintana G, Ni\u00f1o LF. Modelo computacional para la identificaci\u00f3n de endofenotipos y clasificaci\u00f3n de pacientes con artritis reumatoide a partir de datos gen\u00e9ticos, serol\u00f3gicos y cl\u00ednicos, utilizando t\u00e9cnicas de inteligencia computacional. Revis Colomb Reumatol 2015; 22: 90\u2013103.","journal-title":"Revis Colomb Reumatol"},{"key":"e_1_3_4_42_2","unstructured":"Del Risco Morales A. Modelo computacional para el an\u00e1lisis de historias cl\u00ednicas de pacientes con Artritis Reumatoide aplicando bioinform\u00e1tica traslacional y miner\u00eda de textos [Internet]. Bogot\u00e1 Universidad Nacional de Colombia https:\/\/repositorio.unal.edu.co\/handle\/unal\/80693 (2021 accessed 5 June 2024)."},{"key":"e_1_3_4_43_2","unstructured":"Hern\u00e1ndez Tarapu\u00e9s FA. Modelo farmacogen\u00e9tico y cl\u00ednico para la predicci\u00f3n de desenlaces en pacientes con artritis reumatoide tratados con metotrexato y adalimumab https:\/\/repositorio.unal.edu.co\/handle\/unal\/78759 (2020 accessed 1 January 2023)."},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-022-02851-5"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01155"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2024.1406365"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103800"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13133890"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24834"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1011073"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-024-00668-z"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03277-x"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152501"}],"container-title":["Therapeutic Advances in Musculoskeletal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X251342426","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1759720X251342426","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X251342426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:40:06Z","timestamp":1777588806000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1759720X251342426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":52,"alternative-id":["10.1177\/1759720X251342426"],"URL":"https:\/\/doi.org\/10.1177\/1759720x251342426","relation":{},"ISSN":["1759-720X","1759-7218"],"issn-type":[{"value":"1759-720X","type":"print"},{"value":"1759-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"article-number":"1759720X251342426"}}